1. Home
  2. NVAX vs CRCT Comparison

NVAX vs CRCT Comparison

Compare NVAX & CRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • CRCT
  • Stock Information
  • Founded
  • NVAX 1987
  • CRCT 1969
  • Country
  • NVAX United States
  • CRCT United States
  • Employees
  • NVAX N/A
  • CRCT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • CRCT Wholesale Distributors
  • Sector
  • NVAX Health Care
  • CRCT Industrials
  • Exchange
  • NVAX Nasdaq
  • CRCT Nasdaq
  • Market Cap
  • NVAX 1.3B
  • CRCT 1.3B
  • IPO Year
  • NVAX 1995
  • CRCT 2021
  • Fundamental
  • Price
  • NVAX $7.34
  • CRCT $6.06
  • Analyst Decision
  • NVAX Buy
  • CRCT Sell
  • Analyst Count
  • NVAX 5
  • CRCT 3
  • Target Price
  • NVAX $19.00
  • CRCT $4.52
  • AVG Volume (30 Days)
  • NVAX 14.2M
  • CRCT 617.5K
  • Earning Date
  • NVAX 05-08-2025
  • CRCT 05-06-2025
  • Dividend Yield
  • NVAX N/A
  • CRCT 15.68%
  • EPS Growth
  • NVAX N/A
  • CRCT 6.92
  • EPS
  • NVAX 2.97
  • CRCT 0.31
  • Revenue
  • NVAX $1,254,962,000.00
  • CRCT $707,780,000.00
  • Revenue This Year
  • NVAX $40.01
  • CRCT N/A
  • Revenue Next Year
  • NVAX N/A
  • CRCT $1.18
  • P/E Ratio
  • NVAX $2.47
  • CRCT $19.57
  • Revenue Growth
  • NVAX 25.92
  • CRCT N/A
  • 52 Week Low
  • NVAX $5.01
  • CRCT $3.94
  • 52 Week High
  • NVAX $23.86
  • CRCT $7.17
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 55.86
  • CRCT 59.63
  • Support Level
  • NVAX $6.84
  • CRCT $5.86
  • Resistance Level
  • NVAX $7.62
  • CRCT $6.15
  • Average True Range (ATR)
  • NVAX 0.55
  • CRCT 0.23
  • MACD
  • NVAX 0.07
  • CRCT -0.05
  • Stochastic Oscillator
  • NVAX 50.52
  • CRCT 46.48

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

Share on Social Networks: